Literature DB >> 851119

Renal tubular handling of drugs.

E J Cafruny.   

Abstract

The renal excretion of drugs is a vectorial quantity, the resultant of physiologic mechanisms that have directional orientation and magnitude. Magnitude is limited by a variety of extrarenal factors including plasma protein binding and the volume of the total body water. The contributions of the glomeruli and tubules to excretion varies with age. This fact has clinical relevance, especially in newborn children and older patients. Although protein binding reduces the amount of a drug that can be filtered, it usually does not alter the rate of proximal tubular secretion of charged organic molecules. Reabsorption of the filtered fluid from tubular lumens creates concentration gradients favoring the reabsorption of drugs, but the movement of drug molecules out of luminal fluid is hindered by the formation of polar drug metabolites in the liver. Although there are only a few examples in the literature, it is probable that many drugs are reabsorbed by a carrier-mediated process located in the proximal tubules. A major difference exists between the renal handling of chlormerodrin, a neutral mercurial, and of mersalyl, an acidic mercurial. Chlormerodrin is reabsorbed (as a complex with cysteine) by a carrier-mediated process; mersalyl is secreted by one of the organic anion transport systems.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 851119     DOI: 10.1016/0002-9343(77)90403-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  8 in total

1.  Altered flecainide disposition in healthy volunteers taking quinine.

Authors:  A Munafo; G Reymond-Michel; J Biollaz
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  Interrelationship between renal haemodynamics, drug kinetics and drug action.

Authors:  K L Duchin; R W Schrier
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

4.  Steady state serum concentrations and renal clearance of digoxin in neonates, infants and children.

Authors:  H Halkin; M Radomsky; P Millman; S Almog; L Blieden; H Boichis
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953

5.  Hemofiltration clearance of flecainide in a patient with acute renal failure.

Authors:  A Borgeat; J Biollaz; B Freymond; M Bayer-Berger; R Chiolero
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

6.  Is the relative 99mTc-DMSA clearance a useful marker of proximal tubular dysfunction?

Authors:  W H van Luijk; G J Ensing; S Meijer; A J Donker; D A Piers
Journal:  Eur J Nucl Med       Date:  1984

7.  Cefoxitin pharmacokinetics: relation to three different renal clearance studies in patients with various degrees of renal insufficiency.

Authors:  D Kampf; R Schurig; I Korsukewitz; O Brückner
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

8.  Changes in serum levels of quinolones in rats under the influence of experimental trauma.

Authors:  A Trichilis; C Tesserommatis; D Varonos
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2000 Apr-Jun       Impact factor: 2.569

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.